chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received Varivax 7/20/04. Presented 9/13/07 with c/o eruptions starting9-11 and continuing to crop up erythematous lesions with raised center, pruritus. Break through varicella.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a adult patient who received SHINGRIX. Previously administered products included small pox vaccine (received 4 years ago), yellow fever vaccine, tetanus vaccine (every year), cholera vaccine, typhoid vaccine and shingles vaccine (had first shingles vaccine shot a few years ago). On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site pain, injection site erythema, injection site swelling, muscle pain, tiredness, headache, shivering, fever and upset stomach. On an unknown date, the outcome of the injection site pain, injection site erythema, injection site swelling, muscle pain, tiredness, headache, shivering, fever and upset stomach were unknown. It was unknown if the reporter considered the injection site pain, injection site erythema, injection site swelling, muscle pain, tiredness, headache, shivering, fever and upset stomach to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. Four years ago and the patient probably had every shot known to man that was like small pox-every six months-insisted on by crew doing small pox eradication, yellow fever, gamma globulin, tetanus every year, cholera, typhoid, and others vaccines that he did not remember. The patient had first shingles vaccine shot a few years ago. The patient had side effects like Pain, redness, and swelling at the injection site, Muscle pain, Tiredness, Headache, Shivering, fever and upset stomach with new SHINGRIX. The patient stated that, warn the physicians to tell patients to take aspirin or TYLENOL in good doses before getting each of the two SHINGRIX shots, because SHINGRIX is goofy to him.
got a booster dose yesterday instead of a third dose; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL UNDERDOSE (got a booster dose yesterday instead of a third dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.    On 15-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Dec-2021, the patient experienced ACCIDENTAL UNDERDOSE (got a booster dose yesterday instead of a third dose). On 15-Dec-2021, ACCIDENTAL UNDERDOSE (got a booster dose yesterday instead of a third dose) had resolved.            Patient who was severe immunocompromised got a booster dose instead of a third dose. No concomitant medication were provided. No treatment information were given.
Severe muscle pain from lower neck to deep in right scapula. Began the night of 5/6/2021, became more severe overnight into 5/7/2021. Has not resolved. Have been taking Tylenol and using heat packs to relieve pain.
Immediately Dizzy Immediately Light Headed  Next day: Fatigue-Chills-Joint Pain-Severe acid reflux- minor fever
13 year old patient received 1st dose of Moderna vaccine on accident "thought the 13 year old looked 18".; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (13 year old patient received 1st dose of Moderna vaccine on accident "thought the 13 year old looked 18".) in a 13-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Dec-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (13 year old patient received 1st dose of Moderna vaccine on accident "thought the 13 year old looked 18".). On 11-Dec-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (13 year old patient received 1st dose of Moderna vaccine on accident "thought the 13 year old looked 18".) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment drug details were reported. It was reported one unknown 13 year old patient received the 1st dose of Moderna vaccine on 11Dec2021 on accident thought the 13 year old looked 18. No side effects were reported by nurse.
From what I've read online, it's "Covid Arm"  A welt, some itching, soreness, redness, "warm" to the touch at the site of the injection  The weirdness is because I keep reading that this is a delayed reaction. This wasn't delayed. And it's mostly females. I'm not one of those either.
Caller mentions they got three shots in their body and it still hurts.; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE PAIN (Caller mentions they got three shots in their body and it still hurts.) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Caller mentions they got three shots in their body and it still hurts.). At the time of the report, VACCINATION SITE PAIN (Caller mentions they got three shots in their body and it still hurts.) had not resolved.        The action taken with mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown) was unknown.   For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   Concomitant products were not reported.  Treatment medications were not reported.   Reporter did not allow further contact
pt recv vax; exp vesicular rash w/ several vesicles on scalp,three on stomach and one on face and two on back;
My upper chest and throat area hurt when I breathe. It is moderate most of the time, but is more painful when breathing deeply.
Soreness to the injection site for 2-3 days.  Sudden onset of palpitations 5 days after the vaccine, which lasted 3 days.  Diagnosed as Atrial Fibrillation of unknown origin.  No previous history or known risk factors.
I went to the pharmacy to get my 2nd Shot. I waited my 15 minutes.  I went home my arm started to get stiff and I moved it and it worked. Two days later I started getting lesions and the lesions were all over my body. I was very itchy and it would not stop. I went to my PCP and when the Doctor saw my lesions he was not happy. The PCP started me on medications and started doing labs, and biopsy.  The PCP sent to dermatologist. The Dermatologist did the biopsy to get it tested.  The Dermatologist attested that it was reaction to the shot that affects my Kidney and my liver. I am on still seeing the doctor because new lesions are still appearing all over my body.
Fever of 102.6 day after getting the shot, chills, body aches, very bad headache. Issue resolved after30 hours.  Now um just tired.
At the time of vaccination it was approx 6 to 10 days past the 30 days window; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (At the time of vaccination it was approx 6 to 10 days past the 30 days window) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 vaccination.     It was unknown that the patient was ever been diagnosed positive with COVID-19. Patient had no acute illnesses at the time of vaccination and up to one month before.     On 14-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 dosage form. On 14-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (At the time of vaccination it was approx 6 to 10 days past the 30 days window). At the time of the report, EXPIRED PRODUCT ADMINISTERED (At the time of vaccination it was approx 6 to 10 days past the 30 days window) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  A series of patients at a clinic received their second booster dose with a vial of Moderna that went past 30 days at 7-8 degree Celsius. At the time of administration it was approx. 6-10 days past the 30 day window. At the time of report, no patient contacted about any reactions.  Treatment information was not provided.
I experienced itchiness around my genital area, tiredness, dizziness, and chills.
with blood clotting; I had a late menstrual cycle that lasted almost 2 weeks; very painful; very heavy; This is a spontaneous report from a contactable consumer (patient). A 38-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in the left arm on 15May2021 (Batch/Lot Number: ER8736) as dose 2, single (at the age of 38-years-old), for Covid-19 immunisation. Medical history included hyperthyroidism, known allergies: shellfish and COVID-19 from an unknown date and unknown if ongoing. Concomitant medication included methimazole (METHIMAZOLE) 5mg/daily taken for an unspecified indication, start and stop date were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration, administered in the left arm on 24Apr2021 (Batch/Lot Number: EW0169) as dose 1, single (at the age of 37-years-old) for Covid-19 immunisation. The patient had no other vaccine in four weeks. It was reported that less than 2 weeks after her second dose on 15May2021, on 28May2021, she had a late menstrual cycle that lasted almost 2 weeks, very painful, very heavy with blood clotting and not normal for her. She historically has very easy, short (3 days), non-painful cycles. After she had that cycle in late May, she has not had a cycle since then. It is nonexistent. She is not pregnant; she recently took a test with her physician in their office. The patient had not tested for Covid post vaccination. No treatment was administered for the events. The patient had not recovered from the events at the time of the report. The events resulted in Physician Office Visit.   No follow-up attempts are possible. No further information is expected.
patient had an episode of syncope, nausea, emesis, pallor and diaphoretic  around 11:27am after vaccine administration. Ammonia inhalant used pt brought into clinic triage room where provider came to assess . Pt had normal vitals that were taking  a total of 3x during his monitoring  in clinic and was alert and oriented x4.  Pt given juice and water per provider and monitored for an extra 20 min until provider and pt felt comfortable releasing home with strict ER precautions for worsening symptoms.
On the 7th I was leaving the grocery store and my legs stopped working. I almost collapsed in the parking lot. What saved me was my shopping cart. The next week I had an appointment with my doctor already anyways. I talked to him about it, and he gave me a prescription for x-rays and I did that a week and a half later. The next week after that, I had another appointment with my doctor, and he said that there was a lot of bone debris in the middle of my spine and the bones in my neck were straight. And some scoliosis. I have been trying to get an appointment with an orthopedic doctor. Haven?t had luck with that yet. I was also prescribed methocarbamol to try and help with the pain, but it hasn?t been working too well. Also, The beginning of June, I was also having really bad lower back pain. The doctor noted it could have just been a UTI, but no scans were done to confirm anything. Antibiotics did make pain less, but still having back pain.
This spontaneous report was received from a healthcare worker concerning multiple patients of unknown demographics. On unknown dates, multiple different unspecified patients received a dose of M-M-R II that was improperly stored. No adverse effects reported. No product quality complaint was involved. The case is also related to 1506USA002056, 1507USA010861 and 1507USA010859 (same reporter link). Additional information has been requested.
Rash on abdomen; Headache; The following information was received from an employee of doctor's office on 09 Aug 2019.  A 15 year old female received one dose of IXIARO (Japanese encephalitis vaccine, batch number not reported) on 23 July 2019.  She had a history of headaches.  After administration she experienced headache for three days. Approximately one week after administration she experienced rash on abdomen, which did not resolve by time of report.  ---  Follow up received from a consumer on 12 Aug 2019.  Vaccinee identifiers and date of birth were provided. The batch number (JEV18G84E) of IXIARO was also reported.; Sender's Comments: Causality assessed as possible given the kind of events, however the time to onset (one week) for rash is too long for an immediate allergic reaction and might be indicative for a delayed-type hypersensitivity.  ---  Causality assessment not changed, as no new information concerning the assessment was received.
patient states the rash is itchy and on their buttocks, thighs, breast, back, stomach "just all over"; patient states the rash is itchy and on their buttocks, thighs, breast, back, stomach "just all over"; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH PRURITIC (patient states the rash is itchy and on their buttocks, thighs, breast, back, stomach "just all over") and RASH (patient states the rash is itchy and on their buttocks, thighs, breast, back, stomach "just all over") in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     Concomitant products included DESLORATADINE (ARIA DES) for an unknown indication.    On 01-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 21-Apr-2021, the patient experienced RASH PRURITIC (patient states the rash is itchy and on their buttocks, thighs, breast, back, stomach "just all over") and RASH (patient states the rash is itchy and on their buttocks, thighs, breast, back, stomach "just all over"). The patient was treated with PREDNISONE for Rash, at a dose of 40 mg and TRIAMCINOLONE ACETONIDE for Rash, at a dose of 0.1 %. At the time of the report, RASH PRURITIC (patient states the rash is itchy and on their buttocks, thighs, breast, back, stomach "just all over") and RASH (patient states the rash is itchy and on their buttocks, thighs, breast, back, stomach "just all over") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Warm, red, swelling of left arm extending down to elbow yesterday - appears better today, no fever.
HYPOTENSION 3/24/2023 CKD STAGE 5 (GFR <15) HYPOTENSION 3/24/2023 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART HYPOTENSION 3/24/2023 METABOLIC ENCEPHALOPATHY HYPOTENSION 3/24/2023 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART HYPOTENSION 3/24/2023 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART
Patient reported not feeling well 5 minutes after receiving dose.  Became sweaty, light-headed, and reported chest tightness.  Provided ice pack and apple juice.  After 10 minutes, reported blurred vision and hearing difficulties.  Checked O2, heart rate, and blood pressure (WNL).  Contacted emergency medical services after 15 minutes with profuse sweating and chest complaints.  Patient started feeling better after 20 minutes at which time EMS arrived and offered oxygen.
Pt received dose 2 of vaccine only 14 days after dose one. No adverse effects noted, completing VAERS based on recommendations.
This case was reported by a nurse via sales rep and described the occurrence of erythematous rash in a 69-year-old female patient who received SHINGRIX for prophylaxis. On 11th August 2018, the patient received SHINGRIX. In August 2018, less than a month after receiving SHINGRIX, the patient experienced erythematous rash. On an unknown date, the outcome of the erythematous rash was unknown. It was unknown if the reporter considered the erythematous rash to be related to SHINGRIX. Additional details were provided as follows: This case was reported by a Nurse Practitioner (NP). The patient received SHINGRIX on an unknown deltoid. The nurse practitioner reported that the patient experienced a red rash on her chest and under breast after receiving SHINGRIX.
temperature is up again to 100.4, the first time I took it, it was at 101.9 it hasn''t gone underneath 99.4; Nauseous; I have not been feeling good at all; I have been sick ever since Friday which is the 24th and as of today I am still sick; I felt like my head, my brain was frying that''s how sick I was; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-202101878330 (pfizer).  A 68 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 23Dec2021 (Batch/Lot number: unknown) at the age of 68 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Diabetic" (ongoing), notes: Verbatim: Diabetic; "Hypertension" (ongoing), notes: Verbatim: Hypertensive. Concomitant medication(s) included: AMLODIPINE; METFORMIN; BENAZEPRIL. The following information was reported: ILLNESS (non-serious) with onset 24Dec2021, outcome "not recovered", described as "I have been sick ever since Friday which is the 24th and as of today I am still sick"; BODY TEMPERATURE INCREASED (non-serious) with onset 26Dec2021, outcome "not recovered", described as "temperature is up again to 100.4, the first time I took it, it was at 101.9 it hasn''t gone underneath 99.4"; NAUSEA (non-serious) with onset 26Dec2021, outcome "unknown", described as "Nauseous"; MALAISE (non-serious) with onset 26Dec2021, outcome "unknown", described as "I have not been feeling good at all"; HEAD DISCOMFORT (non-serious) with onset 2021, outcome "unknown", described as "I felt like my head, my brain was frying that''s how sick I was". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of illness, body temperature increased, nausea, malaise, head discomfort.  Additional information:Reason for no lot number of Covid-19 vaccine was reported as "It is 33B0B or it's probably BO because then there is BA (not sure).Patient was took Tylenol and Ibuprofen for the treatment of event.   The lot number for bnt162b2 was not provided and will be requested during follow up.
Redness, tender, warm to touch at injection site from deltoid to elbow. Patient also complains of mild pain. Mother has given patient Benadryl and ice pack.
there was pain in my joints (knees and hip); hematoma-like bruising on my palm after using a hammer (it disappeared after a couple days and left no residual markings).; This is a spontaneous report from a contactable nurse (patient). A 53-years-old female patient received first dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot Number: EL9267) dose 1 via an unspecified route of administration, administered in Arm Left on 25Feb2021 at 13:00 as DOSE 1, SINGLE for covid-19 immunisation. Medical history included type 2 diabetes mellitus and allergy to Sulfa and Keflex. Concomitant medications included Canagliflozin (INVOKANA [CANAGLIFLOZIN]), Metformin (METFORMIN). It was reported that the patient received second dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot Number: EN6208) via an unspecified route of administration, administered in Arm Left on 16Mar2021 at 10:30 AM as DOSE 2, SINGLE for covid-19 immunisation and had hair on head is falling out/thinning, gums bled more than usual during dental cleaning, slight incontinence that seems to be worsening (not associated with toileting). On 01mar2021, the patient experienced there was pain in my joints and hematoma-like bruising on my palm after using a hammer (it disappeared after a couple days and left no residual markings).  The patient did not received treatment for the adverse events. Prior to vaccination, the patient did not diagnose with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was reported as not recovered.  No follow-up attempts are needed. No further information is expected.
Patient received INFANRIX, IPOL on Lt upper arm 11/3/08.  Parents noticed fever and cramping abd pain in the first 48 hrs.  Noticed redness, swelling at left upper arm > 48 hrs- progressively got worse, developed generalized urticarial rash all over the body.
This spontaneous report as received from a physician refers to a female (not pregnant) patient who currently would have 22 years old (age at the AE onset unknown). No concurrent conditions or medical history were provided. On an unknown date, the patient was vaccinated with a dose of GARDASIL injection (dose, route of administration, lot# and expiry date unspecified) in her unspecified gynecologist's office. No concomitant medications were reported. It was reported that the patient felt different on the night after receiving the injection (exact date unknown). She was nauseated and developed diarrhea and abdominal cramping with myalgia and shortness of breath on an unspecified date. She had no fever and there was no injection site reaction. The patient sought medical attention via visiting the physician on 22-SEP-2014. The patient was still having significant nausea. The physician had blood work drawn on the patient on an unspecified date. No results have been received at the time of report (25-SEP-2014). The outcome of the events was reported as not recovered. The relatedness between the events and GARDASIL was not reported. Additional information has been requested.
Came down with flu like symptoms.  Turned into a bronchitis type then pneumonia.  Was very sick for ~2 weeks.
Chills, fever to 100.9F, myalgia onset approx. 16hrs after vaccine was administered. Chills lasted 1-2hrs. Fever was still present 24hrs after administration but improved with Tylenol and Aleve.
Knot on arm size of 1/2 a grapefruit (at injection site), swollen right eyelid.
Vasovagal syncope.  Patient passed out as she was leaving the building, approximately 5 minutes after vaccination.  Patient was with her relative who says she dropped her phone and just passed out on the sidewalk outside, for approximately 10 seconds, then regained consciousness on her own.  Gave water, checked BP (129/91), recommended rest. Patient says this has happened before, but not recently.